In 2001, we were invited by the UK CF Trust to form a consortium with two competing research groups at Imperial College, London and the University of Edinburgh.
The aim was that by bringing the three groups together we could share funding and develop a clinically relevant treatment for CF much faster than either group could on its own
Nine years on with a combined staff of over 50, the Consortium is the largest gene therapy group focussed on a single disease anywhere in the world.
We are currently progressing with our first clinical trial programme and are aiming to complete a multi-dose study by the end of 2012.
University of Edinburgh
Imperial College London